Status:
UNKNOWN
Effects of Succinylcholine on Nonintubated Thoracoscopic Surgery
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Tumor of Lung Parenchyma
Complication of Ventilation Therapy
Eligibility:
All Genders
20+ years
Phase:
NA
Brief Summary
A safe and effective surgical environment is important for nonintubated thoracoscopic surgery. The investigators hypothesize that mini-dose succinylcholine can induce ultra-short period of apnea, by w...
Detailed Description
Background: Nonintubated thoracoscopic surgery is the frontier of modern minimal invasive thoracic surgery. A safe and effective surgical environment is established via an iatrogenic open pneumothorax...
Eligibility Criteria
Inclusion
- Adults patients with lung tumors and elective for unilateral thoracoscopic surgery.
Exclusion
- Over weighted, body mass index \> 26 kg/m2.
- Previous thoracic surgery on the attempted operative side.
- Hypoventilation syndrome requiring positive pressure ventilatory support or oxygen at home.
- Relevant systemic disease, including heart failure, liver failure, renal failure with an American Society of Anesthesiologists (ASA) class above 3.
- Difficult airway management.
- Pregnancy.
- Contraindications for succinylcholine, including family history of suspicious malignant hyperthermia, hyperkalemia, or other neuromuscular diseases.
Key Trial Info
Start Date :
March 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 31 2019
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT03469323
Start Date
March 1 2018
End Date
July 31 2019
Last Update
March 20 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital
Taipei, Taiwan, 100